EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study

Koichi Komatsu, Takahide Shinagawa, Motoi Uchino, Hiroki Ikeuchi, Koji Okabayashi, Shiro Oka, Kitaro Futami, Michio Itabashi, Kazuhiro Watanabe, Masatsune Shibutani, Yoshiki Okita, Toshifumi Wakai und 32 weitere

Intestinal Research · 31.10.2026 · 24 (4) · 776-784

DOI: 10.5217/ir.2025.00133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intestinal Research, erschienen am 31.10.2026. Verfasst von Koichi Komatsu und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan. komatsuk-sur@h.u-tokyo.ac.jp. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japanese Society for Cancer of the Colon and Rectum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Ulcerative colitis (UC)-associated colorectal neoplasia (UCAN) in patients with UC and primary sclerosing cholangitis (PSC) has not been studied well in Japan. This retrospective study examined the clinicopathological features and prognosis of UCAN in patients with PSC-UC.

Methods

A total of 808 patients with UCAN were enrolled from 1983 to 2020 and categorized into PSC (PSC-UCAN, n = 26) and no PSC (UCAN-alone, n = 782) groups. Clinicopathological features were compared between the 2 groups, and the 10-year overall survival (OS) and cancer-specific survival (CSS) were analyzed.

Results

The PSC-UCAN group had a shorter UC duration before UCAN diagnosis (12.8 years vs. 16.9 years, P= 0.044), were younger at UCAN diagnosis (47.8 years vs. 53.3 years, P= 0.046), and developed UCAN more frequently in the right-sided colon (34.6% vs. 15.9%, P= 0.028) than the UCAN-alone group. The PSC-UCAN group showed a trend toward a lower proportion of high-grade dysplasia (19.2% vs. 30.7%) and a higher proportion of early-stage cancers (53.9% vs. 31.2%). The 10-year OS (64.6% vs. 79.3%, P=0.080) and CSS (80.8% vs. 83.9%, P=0.60) were comparable.

Conclusions

Patients with PSC-UCAN showed earlier and younger development of UCAN than patients with only UCAN, with a high prevalence in the right-sided colon. Early-stage cancer was more frequently observed in the PSC-UCAN group, despite the shorter duration of UC. Patients with PSC-UC probably benefit from early initiation of surveillance colonoscopy.

Schlagwörter

Stichwörter der Autor:innen

Cholangitis, sclerosingColitis-associated neoplasmsColorectal neoplasmsUlcerative colitis

Autor:innen und Institutionen

  • Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan. komatsuk-sur@h.u-tokyo.ac.jp.
  • Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan.
  • Department of Inflammatory Bowel Disease Surgery, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Surgery, Fukuoka University Chikushi Hospital, Chikushino, Japan.

Förderung

  • Japanese Society for Cancer of the Colon and Rectum

Zitieren

APA

Komatsu, K., Shinagawa, T., Uchino, M., Ikeuchi, H., Okabayashi, K., Oka, S., Futami, K., Itabashi, M., Watanabe, K., Shibutani, M., Okita, Y., Wakai, T., Mizuuchi, Y., Okamoto, K., Yamada, K., Sato, Y., Ogino, T., Kimura, H., Takahashi, K., …, & Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon and Rectum (2026). Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study. Intestinal Research, 24(4), 776-784. https://doi.org/10.5217/ir.2025.00133

Vancouver

Komatsu K, Shinagawa T, Uchino M, Ikeuchi H, Okabayashi K, Oka S, et al. Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study. Intestinal Research. 2026;24(4):776-784. doi:10.5217/ir.2025.00133

BibTeX
@article{Komatsu2026,
  author = {Komatsu, Koichi and Shinagawa, Takahide and Uchino, Motoi and Ikeuchi, Hiroki and Okabayashi, Koji and Oka, Shiro and Futami, Kitaro and Itabashi, Michio and Watanabe, Kazuhiro and Shibutani, Masatsune and Okita, Yoshiki and Wakai, Toshifumi and Mizuuchi, Yusuke and Okamoto, Kinya and Yamada, Kazutaka and Sato, Yu and Ogino, Takayuki and Kimura, Hideaki and Takahashi, Kenichi and Hida, Koya and Kinugasa, Yusuke and Ishida, Fumio and Okuda, Junji and Daito, Koji and Yamamoto, Takayuki and Yamamoto, Seiichiro and Koyama, Fumikazu and Hanai, Tsunekazu and Komori, Koji and Shida, Dai and Arakaki, Junya and Akagi, Yoshito and Yamaguchi, Shigeki and Ueno, Hideki and Matsuda, Keiji and Maemoto, Atsuo and Nezu, Riichiro and Sasaki, Shin and Sunami, Eiji and Noguchi, Tatsuki and Sugihara, Kenichi and Ajioka, Yoichi and Ishihara, Soichiro and Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon and Rectum, Study Group for Inflammatory Bowel Disease Associated Intestinal Cancers by the Japanese Society for Cancer of the Colon and Rectum},
  title = {Colitis-associated colorectal neoplasia in ulcerative colitis with primary sclerosing cholangitis: a nationwide study},
  journal = {Intestinal Research},
  year = {2026},
  volume = {24},
  number = {4},
  pages = {776--784},
  doi = {10.5217/ir.2025.00133}
}
Kostenlos starten →